Minnetronix Announces New Website/Brand Strategy
June 21, 2012
ST. PAUL, Minn. June 21, 2012– Minnetronix announced today its new website and brand strategy to reflect the company’s evolution and growth in the advancement of unique intellectual property within the medical device industry.
Minnetronix, with a 16-year history of significant value creation for its customers, will add to its established medical device development and manufacturing capabilities as it licenses and creates novel technology and intellectual property for the benefit of customers and patients. Minnetronix’ “Innovation and IP Solutions” enterprise will advance the organization’s mission of enhancing patient outcomes through medical device technology.
“For over 15 years, Minnetronix has been dedicated to making a positive impact on patient lives by delivering technical solutions for its customers. As we evolve, we can provide even greater value to patients and medical device companies by identifying and developing original and progressive technologies,” remarked Rich Nazarian, Minnetronix President & CEO.
“Minnetronix has excelled at bringing clients’ proprietary solutions to the marketplace and that will continue to be our focus, but we are now also in a position to contribute clinically impactful and differentiating innovations. We feel the combination of our well established engineering and manufacturing services, with our intellectual property pipeline, creates great potential for effective clinical solutions.”
Minnetronix’ first Innovation and IP Solutions agreement was recently signed with Penn State Research Foundation for its wireless transmission technology. This technology facilitates more mobile and fully implantable systems for use in assist devices in the treatment of Congestive Heart Failure.
Minnetronix provides award-winning product design, development, manufacturing, and IP solutions for the medical device and life science marketplaces. Minnetronix successfully incorporates custom electronic, mechanical and software engineering into finished Class II & III devices and systems such as cardiovascular and monitoring systems, therapeutic and implantable devices, and diagnostic instruments.
Minnetronix has led over 150 design and manufacturing projects for nearly 100 different medical device and life science companies, ranging in size from small start-ups to large established firms. Minnetronix is ISO 13485 certified and is an FDA registered manufacturer.